Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
47.08
-4.53 (-8.78%)
At close: Jul 31, 2026, 4:00 PM EDT
46.92
-0.16 (-0.34%)
After-hours: Jul 31, 2026, 7:59 PM EDT
Novo Nordisk Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 327,800 | 309,064 | 290,403 | 232,261 | 176,954 | 140,800 | |
Revenue Growth | 8.13% | 6.43% | 25.03% | 31.25% | 25.68% | 10.91% |
Cost of Revenue | 59,496 | 58,788 | 44,522 | 35,765 | 28,448 | 23,658 |
Gross Profit | 268,304 | 250,276 | 245,881 | 196,496 | 148,506 | 117,142 |
Selling, General & Admin | 67,384 | 70,279 | 67,377 | 61,598 | 50,684 | 41,058 |
Research & Development | 52,015 | 52,039 | 48,062 | 32,443 | 24,047 | 17,772 |
Other Operating Expenses | 420 | 300 | 2,103 | -119 | -1,034 | -332 |
Total Operating Expenses | 119,819 | 122,618 | 117,542 | 93,922 | 73,697 | 58,498 |
Operating Income | 148,485 | 127,658 | 128,339 | 102,574 | 74,809 | 58,644 |
Interest Income | 12,288 | 9,660 | 6,198 | 2,945 | 239 | 2,887 |
Interest Expense | -5,094 | -6,778 | -7,346 | -845 | -5,986 | -2,451 |
Total Non-Operating Income (Expense) | 7,194 | 2,882 | -1,148 | 2,100 | -5,747 | 436 |
Pretax Income | 155,679 | 130,540 | 127,191 | 104,674 | 69,062 | 59,080 |
Provision for Income Taxes | 33,722 | 28,106 | 26,203 | 20,991 | 13,537 | 11,323 |
Net Income | 121,957 | 102,434 | 100,988 | 83,683 | 55,525 | 47,757 |
Net Income to Common | 121,957 | 102,434 | 100,988 | 83,683 | 55,525 | 47,757 |
Net Income Growth | 16.58% | 1.43% | 20.68% | 50.71% | 16.27% | 13.33% |
Shares Outstanding (Basic) | 4,445 | 4,443 | 4,454 | 4,483 | 4,531 | 4,593 |
Shares Outstanding (Diluted) | 4,448 | 4,448 | 4,463 | 4,495 | 4,545 | 4,606 |
Shares Change | -0.20% | -0.34% | -0.71% | -1.10% | -1.34% | -1.58% |
EPS (Basic) | 27.45 | 23.06 | 22.67 | 18.67 | 12.26 | 10.40 |
EPS (Diluted) | 27.41 | 23.03 | 22.63 | 18.62 | 12.22 | 10.37 |
EPS Growth | 16.74% | 1.77% | 21.54% | 52.37% | 17.84% | 15.16% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 118,456 | 58,962 | 73,804 | 83,102 | 66,741 | 48,665 |
Free Cash Flow Growth | -9.84% | -20.11% | -11.19% | 24.51% | 37.14% | 5.50% |
Free Cash Flow Per Share | 26.63 | 13.26 | 16.54 | 18.49 | 14.69 | 10.57 |
Dividends Per Share | 11.700 | 11.700 | 11.400 | 9.400 | 6.200 | 5.200 |
Dividend Growth | 2.63% | 2.63% | 21.28% | 51.61% | 19.23% | 14.29% |
Gross Margin | 81.85% | 80.98% | 84.67% | 84.60% | 83.92% | 83.20% |
Operating Margin | 45.30% | 41.30% | 44.19% | 44.16% | 42.28% | 41.65% |
Profit Margin | 37.20% | 33.14% | 34.78% | 36.03% | 31.38% | 33.92% |
FCF Margin | 36.14% | 19.08% | 25.41% | 35.78% | 37.72% | 34.56% |
EBITDA | 170,173 | 149,640 | 147,446 | 111,987 | 82,171 | 64,669 |
EBITDA Margin | 51.91% | 48.42% | 50.77% | 48.22% | 46.44% | 45.93% |
EBIT | 148,485 | 127,658 | 128,339 | 102,574 | 74,809 | 58,644 |
EBIT Margin | 45.30% | 41.30% | 44.19% | 44.16% | 42.28% | 41.65% |
Effective Tax Rate | 21.66% | 21.53% | 20.60% | 20.05% | 19.60% | 19.17% |